Free Trial
NYSE:ENFN

Enfusion (ENFN) Stock Price, News & Analysis

Enfusion logo
$10.85 +0.05 (+0.45%)
Closing price 04/17/2025
Extended Trading
$10.85 0.00 (0.00%)
As of 04/17/2025 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Enfusion Stock (NYSE:ENFN)

Key Stats

Today's Range
$10.74
$10.87
50-Day Range
$10.85
$10.85
52-Week Range
$7.83
$11.80
Volume
2.46 million shs
Average Volume
717,080 shs
Market Capitalization
$1.40 billion
P/E Ratio
271.29
Dividend Yield
N/A
Price Target
$12.25
Consensus Rating
Hold

Company Overview

Receive ENFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter.

ENFN Stock News Headlines

Clearwater Analytics reinstated with an Overweight at JPMorgan
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
Clearwater Analytics Finalizes Acquisition of Enfusion
See More Headlines

ENFN Stock Analysis - Frequently Asked Questions

Enfusion's stock was trading at $10.30 at the beginning of 2025. Since then, ENFN stock has increased by 5.3% and is now trading at $10.8490.

Enfusion, Inc. (NYSE:ENFN) announced its quarterly earnings data on Monday, March, 3rd. The company reported $0.01 EPS for the quarter, missing analysts' consensus estimates of $0.03 by $0.02. The firm earned $52.94 million during the quarter, compared to the consensus estimate of $53.98 million. Enfusion had a net margin of 1.70% and a trailing twelve-month return on equity of 6.67%.

Enfusion (ENFN) raised $300 million in an initial public offering on Thursday, October 21st 2021. The company issued 18,750,000 shares at a price of $15.00-$17.00 per share.

Shares of ENFN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enfusion investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Alphabet (GOOG).

Company Calendar

Last Earnings
3/03/2025
Today
7/12/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Prepackaged software
Sub-Industry
Computer Software
Current Symbol
NYSE:ENFN
CIK
1868912
Fax
N/A
Employees
890
Year Founded
N/A

Price Target and Rating

High Price Target
$13.00
Low Price Target
$11.50
Potential Upside/Downside
+12.9%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.03
Trailing P/E Ratio
271.29
Forward P/E Ratio
180.82
P/E Growth
1.85
Net Income
$6.03 million
Net Margins
1.70%
Pretax Margin
3.64%
Return on Equity
6.67%
Return on Assets
4.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.62
Quick Ratio
3.62

Sales & Book Value

Annual Sales
$201.61 million
Price / Sales
6.94
Cash Flow
$0.14 per share
Price / Cash Flow
78.75
Book Value
$0.61 per share
Price / Book
17.79

Miscellaneous

Outstanding Shares
129,001,000
Free Float
81,720,000
Market Cap
$1.40 billion
Optionable
Optionable
Beta
0.92

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NYSE:ENFN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners